assessment of transient elastography (fibroscan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: a systematic review and meta-analysis
نویسندگان
چکیده
background: transient elastography (te) is a new modality for the diagnosis of liver fibrosis caused by various etiologies. this study was conducted to determine the accuracy of te in detecting the different stages of liver fibrosis in non-alcoholic fatty liver disease (nafld) patients. methods: medline/pubmed, embase, ovid, cochrane library, american college of physicians (acp) journal club, google scholar, database of abstracts of reviews of effects, and web of science that evaluated the liver stiffness by means of te and liver biopsy were enrolled in this systematic review and meta-analysis. published articles were extracted from 2002 to march 2015. results: a total of 7 articles from 114 papers were included which consisted of 698 patients. the results indicated that when f ≥3, the outcomes were 93.7% (95% confidence interval (ci): 92-95.5), 91.1% (95% ci: 89-93.2), 82.4% (95% ci: 79.9-84.9), and 95.9% (95% ci: 94.4-97.4) for sensitivity, specificity, positive predictive value (ppv) and negative predictive value (npv), respectively. with fibrosis stage ≥4, it has reached the sensitivity of 96.2 % (95% ci: 94.5-97.8), a specificity of 92.2% (95% ci: 89.9-94.6), a ppv of 5.5% (95% ci: 51.2-59.8) and npv of 98.5% (95% ci: 97.4-99.5). conclusion: we concluded that as the pathological fibrosis increases, the sensitivity, specificity and npv of te in the diagnosis of fibrosis improves in nafld patients. te can be considered as a unique alternative instead of liver biopsy in nafld patients and it has an important role in the exclusion of liver cirrhosis. more studies are required to confirm the results.
منابع مشابه
Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis
Background: Transient elastography (TE) is a new modality for the diagnosis of liver fibrosis caused by various etiologies. This study was conducted to determine the accuracy of TE in detecting the different stages of liver fibrosis in non-alcoholic fatty liver disease (NAFLD) patients. Methods: MEDLINE/PubMed, Embase, Ovid, Cochrane Library, American College of Physicians (ACP) Journal Club...
متن کاملAssessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis
BACKGROUND Transient elastography (TE) is a new modality for the diagnosis of liver fibrosis caused by various etiologies. This study was conducted to determine the accuracy of TE in detecting the different stages of liver fibrosis in non-alcoholic fatty liver disease (NAFLD) patients. METHODS MEDLINE/PubMed, Embase, Ovid, Cochrane Library, American College of Physicians (ACP) Journal Club, G...
متن کاملClinical Manifestations and Diagnosis of Non-Alcoholic Fatty Liver Disease
Background & Objective: Nonalcoholic fatty liver diseases (NAFLD) is the major cause of hepatocellular carcinoma and increases the risk of mortality. Understanding the trends of its clinical and biochemical changes is essential to identify patients with NAFLD that are at the greatest risk of nonalcoholic steatohepatitis (NASH) and cirrhosis in Iran. M...
متن کاملEvaluation of the effects of resveratrol on non-alcoholic fatty liver disease A systematic review study
Introduction: Non-alcoholic fatty liver disease (NAFLD) is a condition in which triglycerides accumulate in liver cells without a history of alcohol consumption. Evidence has shown that auxiliary treatments, including the use of antioxidant compounds, can be effective in improving nonalcoholic fatty liver. Resveratrol is an antioxidant compound that has been shown to be beneficial in some disea...
متن کاملTransient elastography in non-alcoholic fatty liver disease.
Non-alcoholic fatty liver disease (NAFLD) is a relevant issue in public health owing to its epidemiological burden. It represents the most common chronic liver disease in the general population and is expected to increase in future as a result of an ageing population. Liver biopsy is still considered the "gold standard" for distinguishing the broad range of NAFLD. However, liver biopsy is often...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
caspian journal of internal medicineجلد ۷، شماره ۴، صفحات ۲۴۲-۲۵۲
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023